The specific benefit of RTN4-mediated pyroptosis in enhancing the efficacy of antitumor immune therapy lies in its capacity to increase the expression of PD-L1 in tumor cells and subsequently induce immune-mediated tumor cell death. The gene discussed is CD274; the disease is neoplasm.